alexa Case-Reoprt: Signet Cell Colorectal Cancer

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Case-Reoprt: Signet Cell Colorectal Cancer

Poornima Sharma, Aung Oakkar, et al. of Tate Cancer Center, University of Maryland Baltimore Washington Medical Center ressolved a case Contemporary Management of Non-Appendicular Mucinous and Signet Cell Colorectal Cancer in Community Setting. They conclude Mucinous and signet cell histology is a clinicopathological distinct type of colorectal cancer that carries a negative impact on patient survival. Despite multimodality management and advance in chemotherapy, stage IV mucinous-signet cell colorectal cancer has a dismal prognosis. New treatment strategies for mucinous-signet cell cancer are needed. (Full-articles

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger